Items

• The Therapeutic Potential of 2‑{[4‑(2‑methoxyphenyl) piperazin‑1‑yl]alkyl}‑1H‑benzo[d]imidazoles as Ligands for Alpha1‑Adrenergic Receptor ‑ Comparative In Silico and In Vitro Study (2022)

  J. Penjišević, V. Šukalović, D. Andrić, R. Suručić, S. Kostić-Rajačić, The Therapeutic Potential of 2‑{[4‑(2‑methoxyphenyl) piperazin‑1‑yl]alkyl}‑1H‑benzo[d]imidazoles as Ligands for Alpha1‑Adrenergic Receptor ‑ Comparative In Silico and In Vitro Study, APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2022

• Structure-activity and binding orientations analysis of potent, newly synthesized, acetylcholinesterase inhibitors (2023)

  M. Krunić, J. Penjišević, R. Suručić, S. Šegan, S. Kostić-Rajačić, I. Jevtić, Structure-activity and binding orientations analysis of potent, newly synthesized, acetylcholinesterase inhibitors, JOURNAL OF MOLECULAR STRUCTURE, 2023

• Multi-target potential of newly designed tacrine-derived cholinesterase inhibitors: Synthesis, computational and pharmacological study (2024)

  I. Jevtić, R. Suručić, G. Tovilović-Kovačević, N. Zogović, S. Kostić-Rajačić, D. Andrić, J. Penjišević, Multi-target potential of newly designed tacrine-derived cholinesterase inhibitors: Synthesis, computational and pharmacological study, BIOORGANIC & MEDICINAL CHEMISTRY, 2024